Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure
Crossref DOI link: https://doi.org/10.1007/s11095-015-1785-0
Published Online: 2015-09-03
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fujita, Ken-ichi
Masuo, Yusuke
Okumura, Hidenori
Watanabe, Yusuke
Suzuki, Hiromichi
Sunakawa, Yu
Shimada, Ken
Kawara, Kaori
Akiyama, Yuko
Kitamura, Masanori
Kunishima, Munetaka
Sasaki, Yasutsuna
Kato, Yukio
Text and Data Mining valid from 2015-09-03